Advance: The effect of cinacalcet plus low-dose vitamin D on vascular calcification in hemodialysis patients - Methods

被引:0
|
作者
Floege, J.
Sprague, S.
Droge, J.
Banos, A.
Chertow, G.
机构
[1] Rhein Westfal TH Aachen, D-5100 Aachen, Germany
[2] Northwestern Univ, Evanston NW Healthcare, Evanston, IL USA
[3] Amgen Inc, Thousand Oaks, CA USA
[4] Amgen Ltd, Uxbridge, Middx, England
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
60
引用
收藏
页码:A39 / A39
页数:1
相关论文
共 50 条
  • [1] The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
    Raggi, Paolo
    Chertow, Glenn M.
    Torres, Pablo Urena
    Csiky, Botond
    Naso, Agostino
    Nossuli, Kaldun
    Moustafa, Moustafa
    Goodman, William G.
    Lopez, Nicole
    Downey, Gerry
    Dehmel, Bastian
    Floege, Juergen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) : 1327 - 1339
  • [2] A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECTS OF CINACALCET PLUS LOW-DOSE VITAMIN D ON VASCULAR CALCIFICATION IN HEMODIALYSIS PATIENTS
    Raggi, P.
    Cherlow, G.
    Block, G.
    Urena, P.
    Csiky, B.
    Naso, A.
    Nossuli, K.
    Moustafa, M.
    Goodman, W.
    Lopez, N.
    Downey, G.
    Dehmel, B.
    Floege, J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A92 - A92
  • [3] Economic Analysis of Cinacalcet in Combination With Low-Dose Vitamin D Versus Flexible-Dose Vitamin D in Treating Secondary Hyperparathyroidism in Hemodialysis Patients
    Shireman, Theresa I.
    Almehmi, Ammar
    Wetmore, James B.
    Lu, John
    Pregenzer, Mark
    Quarles, L. Darryl
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (06) : 1108 - 1116
  • [4] LOW VITAMIN D AS A MODIFYING FACTOR IN THE RELATIONSHIP BETWEEN OBESITY AND VASCULAR CALCIFICATION IN HEMODIALYSIS PATIENTS
    Kim, Jwa-Kyung
    Kim, Young Su
    Song, Young Rim
    Kim, Sung Gyun
    Kim, Hyung Jik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 302 - 303
  • [5] Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism
    Urena-Torres, Pablo
    Bridges, Ian
    Christiano, Cynthia
    Cournoyer, Serge H.
    Cooper, Kerry
    Farouk, Mourad
    Kopyt, Nelson P.
    Rodriguez, Mariano
    Zehnder, Daniel
    Covic, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (05) : 1241 - 1254
  • [6] Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols
    Chertow, Glenn M.
    Lu, Z. John
    Xu, Xiao
    Knight, Tyler G.
    Goodman, William G.
    Bushinsky, David A.
    Block, Geoffrey A.
    HEMODIALYSIS INTERNATIONAL, 2012, 16 (02) : 188 - 197
  • [7] Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
    Ketteler, Markus
    Martin, Kevin J.
    Wolf, Myles
    Amdahl, Michael
    Cozzolino, Mario
    Goldsmith, David
    Sharma, Amit
    Marx, Steven
    Khan, Samina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (08) : 3270 - 3278
  • [8] Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
    Wetmore, James B.
    Liu, Shiguang
    Krebill, Ron
    Menard, Rochelle
    Quarles, L. Darryl
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (01): : 110 - 116
  • [9] Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
    Amit Sharma
    Thomas S. Marshall
    Samina S. Khan
    Beverly Johns
    Clinical Drug Investigation, 2014, 34 : 107 - 115
  • [10] Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
    Sharma, Amit
    Marshall, Thomas S.
    Khan, Samina S.
    Johns, Beverly
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 107 - 115